University of California, Los Angeles at SABCS 2026

Dec 8–11, 2026 San Antonio, TX ~11k attendees Website

University of California, Los Angeles brings 13 presentations to SABCS 2026 in San Antonio. The university presents on side effects of antibody-drug conjugates, Breast Cancer Index testing, the genomics of triple-negative disease by age and resistance to elacestrant, and takes two discussant seats.

OrganizationSABCS 2026 Attendance
Academic
A public research university in Los Angeles with a medical school and cancer research programs.
Poster
Wed Dec 9
12:30–2pm
Poster
Wed Dec 9
12:30–2pm
Implications of Early BCI Testing in ER+ Invasive Breast Cancer
Exhibit Hall
Clinical Biomarkers, Translational Research, and Precision Medicine
Poster
Wed Dec 9
12:30–2pm
Genomic and immunologic landscape of triple-negative breast cancer by age: A comprehensive analysis of over 3,000 patients
Exhibit Hall
Clinical Biomarkers, Translational Research, and Precision Medicine
Poster
Wed Dec 9
12:30–2pm
Germline mirSNP Signatures of Immune Checkpoint Inhibition in Pregnancy-Associated Breast Cancer
Exhibit Hall
Clinical Biomarkers, Translational Research, and Precision Medicine
Poster
Wed Dec 9
5–6:30pm
Poster
Thu Dec 10
12:30–2pm
The Economic Impact of AI Triaging to Enable Same-day Diagnostic Work-up in Breast Cancer Screening Practice
Exhibit Hall
Artificial Intelligence, Computational Biology, and Systems Biology
Poster
Thu Dec 10
12:30–2pm
Utilization of Adjuvant Ribociclib in Eligible Patients with HR+/HER2- Stage II/III Early Breast Cancer (eBC)
Exhibit Hall
Breast Cancer: Early Stage - Hormone Receptor Positive
Poster
Thu Dec 10
12:30–2pm
Germline mirSNPs Identify Women at Increased Risk of Menopausal Hormonal Therapy-Associated Breast Cancer
Exhibit Hall
Breast Cancer Risk, Genetics, and Prevention
Session
Fri Dec 11
9:15–11:45am
General Session 3
Hall 1
Poster
Fri Dec 11
12:30–2pm
Identifying Clinicopathologic Features Associated with BCI Minimal Risk of Recurrence in Patients with ER+ Early-Stage Invasive Breast Cancer
Exhibit Hall
Clinical Biomarkers, Translational Research, and Precision Medicine
Poster
Fri Dec 11
12:30–2pm
Germline microRNA-based variants predict fractionation-specific late radiation adverse events in breast cancer
Exhibit Hall
Clinical Biomarkers, Translational Research, and Precision Medicine

Explore the full SABCS 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Antonio. Leave your work email and we’ll be in touch.

Privacy

Download the full SABCS 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at University of California, Los Angeles

Tell us what you sell and we’ll find the people at University of California, Los Angeles most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with the San Antonio Breast Cancer Symposium, UT Health San Antonio or the American Association for Cancer Research. Organization details are derived from SABCS’s published program and exhibitor list. Submit a correction